A Phase II Study to Evaluate the Efficacy and Safety of SYH2059 Tablets in Adult Patients With Idiopathic Pulmonary Fibrosis
Clinical trial NCT07600021 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07600021
- Sponsor
- InnovStone Therapeutics Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2027-10-30
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.